What Does Sermorelin Do?

Dec 24, 2024 Leave a message

Sermorelin is a 29-amino acid peptide derivative of the endogenous peptide hormone GHRH, that retains the full functional activity of GHRH, due to the fact that the sermorelin peptide includes the GHRH receptor binding domain.

Sermorelin has a rapid half life of 11-12 minutes when administered via injection and exerts its effects by binding to the GHRH receptor at the pituitary gland. This leads to stimulation of growth hormone secretion by the pituitary gland, independent of changes to other hormones such as luteinizing hormone (LH), follicle-stimulating hormone (FHS), prolactin, cortisol, glucose, glucagon, or thyroid stimulating hormone (TSH).

Unlike administration of GH which introduces an unnatural, single bolus of the hormone, sermorelin leads to stimulation of pulsatile GH secretion that mirrors endogenous secretion patterns . It is hypothesized that GH secretion in this pulsatile fashion over a 24-hour period is important for reaping the full benefits of the GH-IGF-1 axis.

An important byproduct of sermorelin's targeting of the underlying regulatory feedback pathway is that GH and IGF-1 levels are maintained in a physiological range, avoiding the negative consequences of GH therapy.

Similar to hGH administration, the most notable effects of sermorelin are around increased lipolysis due to direct action of GH on adipose tissue and increased lean body mass due to upregulation of IGF-1 secretion.

Due to these unique properties, sermorelin is useful to researchers interested in an alternative to exogenous rhGH administration that can produce the following effects, all otherwise associated with rhGH:

• Diagnosis of growth hormone deficiency

• Treatment of low IGF-1 levels

• Improvements in body composition and fat loss

• Improved muscle strength and exercise performance

• Increased skin thickness

• Improved memory and well-being

• Increased resting energy expenditure

 

product-623-526

 

Send Inquiry

whatsapp

Phone

E-mail

Inquiry